Pharma Journalist 8947 posts 0 comments

Knight Therapeutics Inc. announced that it has entered into a definitive agreement under which Knight will acquire a 51.21% interest in Biotoscana Investments S.A. (B3: GBIO33) from a…
Read More...

GlaxoSmithKline plc announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure (hHF) in adults with…
Read More...

Verseau Therapeutics, Inc. launched with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration's (FDA) approval of STELARA® (ustekinumab) for the treatment of adult…
Read More...

Biogen Inc. and Samsung Bioepis announced that they will present new real-world data from the companies’ anti-TNF biosimilar portfolio, which includes FLIXABI (infliximab) and IMRALDI…
Read More...

SMi Reports: Overview of the workshops for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. SMi’s highly anticipated Parallel Trade…
Read More...

Alexion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved ULTOMIRIS (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome (aHUS)…
Read More...

Boston – October 18, 2020 Continuous process first gained pharma and biotech’s attention in early 2010. It has taken Vertex and Janssen years before Symdeko and PREZISTA approved by…
Read More...

SMi Reports: James Drinkwater and Olivier Chancel release an invitation chair letter for the Pharmaceutical Microbiology Conference, in London. SMi Group is delighted to present the…
Read More...